Detection method for angiogenesis promoting quality marker of salted semen cuscutae and application of detection method

The quality markers of salt dodder pro-angiogenesis were screened by UHPLC-Q/TOF-MS and gray correlation analysis method, which solved the complexity of basic research on pharmacoactive substances of salt dodder, and kaempol-3-O-β-D- Glucuronidine is the main substance, achieving high-efficiency evaluation of the efficacy of salt dodder.

CN118961915APending Publication Date: 2024-11-15ANHUI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202410945019.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-15
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The prior art is difficult to effectively screen and verify the quality markers of angiogenic vascuta in salt, which leads to complex research on quality evaluation of traditional Chinese medicine and basic research on pharmacodynamic substances, and lacks systematic screening methods.

Method used

The decoction method of salt Cuscuta is prepared by water decoction. After administration by SD rats, serum samples are taken, combined with ultra-high performance liquid chromatography-quadratic rod/time-flight-mass spectrometry (UHPLC-Q/TOF-MS) analysis and gray Correlation analysis method, screen out mass markers that promote angiogenesis, construct a 'spectrum-effect' relationship model, and screen chemical components closely related to drug efficacy.

Benefits of technology

Kaanthus-3-O-β-D-glucuronidine was successfully screened as the main material basis for the effect of salt Cuscuta, achieving high sensitivity and reproducibility of the quality markers for pro-angiogenesis of salt Cuscuta. Good screening and accurate evaluation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118961915A_ABST
    Figure CN118961915A_ABST
Patent Text Reader

Abstract

The invention discloses a method for screening a quality marker for promoting angiogenesis of salted semen cuscutae. The method comprises the following steps: decocting the salted semen cuscutae to obtain a water decoction; intragastric administration is carried out on the SD rat, anesthesia and blood collection are carried out after last intragastric administration, and centrifugation is carried out to obtain a rat drug-containing serum sample; the method comprises the following steps: taking reference substances such as astragalin, quercetin, isoquercitrin, kaempferol, isorhamnetin and palmitic acid to prepare a mixed reference substance solution; and analyzing the salted semen cuscutae water decoction, the rat drug-containing serum and the reference substance solution by using ultra-high performance liquid chromatography-quadrupole / time-of-flight-mass spectrometry, characterizing the in-vivo and in-vitro chemical components of the salted semen cuscutae, and drawing a response intensity-time curve. And performing multi-dimensional angiogenesis promotion evaluation on the drug-containing serum of the rats at different time points, and drawing a drug effect-time curve. The method comprises the following steps: fitting a response intensity-time curve of each migration component of serum with a drug effect-time curve of the serum to construct a spectrum-effect relation model, and screening out the quality marker for promoting angiogenesis through a correlation analysis and gray correlation analysis method.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a method for screening a quality marker of angiogenesis promoted by Cuscuta australis, and specifically belongs to the field of extraction of active ingredients of traditional Chinese medicine and quality evaluation of traditional Chinese medicine. Background Art

[0002] Cuscuta is the dried mature seed of Cuscuta australis R.Br. or Cuscutachinensis Lam. of the Convolvulaceae family. It is a parasitic plant with the effects of tonifying the liver and kidney, calming the fetus, consolidating the essence and reducing urine. It is often used clinically to treat liver and kidney deficiency, kidney deficiency and fetal leakage, and fetal movement disorders. The inventor's research team found in the early stage that the curative effect of salt-roasted Cuscuta in tonifying the kidney and calming the fetus is better than that of raw products, and can promote the expression of vascular endothelial growth factor (VEGF) and decidual microvascular density (CD31), but the material basis for its efficacy is still unknown. Modern research has found that angiogenesis is an important factor involved in the development of the fetus and placenta. It can be seen that promoting the construction of the vascular network at the maternal-fetal interface is the key to preventing abortion. Therefore, it is crucial to carry out the screening of angiogenesis-promoting components of salt Cuscuta for the quality evaluation of salt Cuscuta.

[0003] Traditional Chinese medicine contains complex and diverse ingredients, and its pharmacological effects have the characteristics of "multi-component, multi-target" synergistic effects, which makes the study of the material basis of the efficacy of traditional Chinese medicine difficult and complicated. The spectrum-effect correlation of traditional Chinese medicine has received widespread attention in recent years. It provides a way to clarify the active material basis of traditional Chinese medicine and control the quality of traditional Chinese medicine. The "spectrum" in the spectrum-effect correlation of traditional Chinese medicine usually refers to the serum spectrum, and the "effect" refers to the efficacy of traditional Chinese medicine. The characteristic peak response intensity in the spectrum is combined with the efficacy of traditional Chinese medicine, and the active ingredients closely related to the effect are screened through correlation analysis methods. Grey correlation analysis (GRA) is a commonly used analysis form in the spectrum-effect relationship of traditional Chinese medicine. It is a grey system analysis method based on biological effects and has been widely used to study the material basis of the pharmacological effects of important compounds. Its basic theory is to calculate the correlation between the characteristic sequence and the parent sequence based on the sample data of each factor, and use the similarity between the curves to judge the correlation between the factors. Its characteristics are that it does not require too much data information collection. The method is simple and can accurately and comprehensively evaluate the material basis of the efficacy of traditional Chinese medicine. Although most literature has reported that salt dodder has the effect of promoting angiogenesis at the maternal-fetal interface, there are few reports on the screening and experimental verification of quality markers for this effect. Therefore, the present invention can fill this gap and has important guiding significance for screening quality markers of salt dodder for promoting angiogenesis and improving the quality standards of Chinese herbal medicines. Summary of the invention

[0004] The purpose of the present invention is to provide a method for screening a quality marker of angiogenesis promoted by Cuscuta australis.

[0005] A method for screening a quality marker of angiogenesis promoted by Cuscuta australis, comprising the following steps:

[0006] S1: decoct the salt dodder seed medicinal material according to the water decoction method, and concentrate it to a concentration of 1.08 g / mL to obtain the salt dodder seed water decoction.

[0007] S2: SD rats were intragastrically administered with a dose of 10.8 g / kg, once a day, for 7 consecutive days. Blood was collected from the abdominal aorta after the last intragastrically administered dose (1h, 2h, 4h, 6h, 8h, 24h) using 10% urethane anesthesia, and the blood was centrifuged to obtain the drug-containing serum samples of rats.

[0008] S3: Accurately weigh appropriate amounts of reference substances including astragalus glycosides, quercetin, isoquercetin, kaempferol, isorhamnetin, and palmitic acid, add methanol to dissolve and make up to volume to prepare reference substance stock solutions. Take each reference substance solution and add methanol to prepare a 10 μg / mL mixed reference substance solution.

[0009] S4: The serum sample obtained in S2 is subjected to steps such as adding an extracting solution, vortexing, nitrogen blowing, and re-dissolving to obtain a serum sample that can be used in the instrument.

[0010] S5: The samples in S1, S3 and S4 were analyzed by ultra-high performance liquid chromatography-quadrupole / time-of-flight-mass spectrometry (UHPLC-Q / TOF-MS) to characterize the in-vivo and out-vivo chemical components of Cuscuta australis and to plot the response intensity-time curve.

[0011] S6: Perform a multi-dimensional evaluation of the angiogenesis-promoting effect of the salt dodder serum at different time points in S2, and draw a drug efficacy-time curve.

[0012] S7: Fit the response intensity-time curves of each serum migration component in S5 with the efficacy-time curve in S6 to construct a "spectrum-effect" relationship model, and screen out quality markers that promote angiogenesis through correlation analysis methods (grey correlation analysis).

[0013] Among them, the efficacy evaluation indicators of salt dodder in promoting angiogenesis described in step S6 are the effect of salt dodder serum on the proliferation activity of human umbilical vein endothelial cells (HUVEC), the effect of salt dodder serum on the number of vascular branches of HUVEC cells, and the effect of salt dodder serum on the formation of vascular length of HUVEC cells.

[0014] Grey correlation analysis was performed based on the efficacy indicators of promoting angiogenesis and the blood-entering components of salt dodder seeds. The efficacy-time curve was set as the parent sequence variable, and the response intensity-time curve of each component was set as the characteristic sequence variable. The correlation between the two was calculated, and the chemical components associated with the time change of drug efficacy were screened, so as to explore the quality markers of salt dodder seeds in promoting angiogenesis.

[0015] The chromatographic conditions of the high performance liquid chromatography in step S5 are: Waters UPLC BEH C18 chromatographic column (2.1 mm×100 mm, 1.7 μm), mobile phase is (A) 0.1% formic acid aqueous solution and (B) 0.1% formic acid acetonitrile. The mass spectrometry conditions are: bombardment energy: 40 eV, collision energy difference: 20 V, nebulization pressure (GS1): 55 Psi, auxiliary pressure: 55 Psi, air curtain pressure: 35 Psi, temperature: 550° C., spray voltage: 5500 V (positive ion mode) or -4000 V (negative ion mode).

[0016] The beneficial effects of the present invention are:

[0017] (1) The in vivo and in vitro components of the decoction of Cuscuta australis were comprehensively and systematically analyzed by UHPLC-Q / TOF-MS detection technology and spectral-effect correlation analysis grey correlation analysis method, and the quality markers that promote angiogenesis were screened out. This method has high sensitivity, good reproducibility and high accuracy.

[0018] (2) Through spectrum-effect correlation research, the present invention found that the response intensity of kaempferol-3-O-β-D-glucuronide has the highest correlation with the efficacy, and is the main material basis for the efficacy of salt dodder seeds. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1A This is the total ion chromatogram of Cuscuta salina in negative ion mode. Figure 1B This is the total ion chromatogram of Cuscuta australis in positive ion mode.

[0020] Figure 2 It is the mass spectrometry fragmentation pathway of hyperoside.

[0021] Figure 3 It is the isochlorogenic acid C cleavage pathway.

[0022] Figure 4A is the total ion chromatogram of blank serum in positive ion mode; Figure 4B is the total ion chromatogram of blank serum in negative ion mode; Figure 4C This is the total ion current of drug-containing serum collected 1 hour ago in positive ion mode; Figure 4D This is the total ion current of drug-containing serum collected 1 hour ago in negative ion mode; Figure 4E This is the total ion current of drug-containing serum collected 2 hours ago in positive ion mode; Figure 4F This is the total ion current of drug-containing serum collected 2 hours ago in negative ion mode; Figure 4GThis is the total ion current of drug-containing serum collected 4 hours ago in positive ion mode; Figure 4H This is the total ion current of drug-containing serum collected 4 hours ago in negative ion mode; Fig. 4I This is the total ion current of drug-containing serum collected 6 hours ago in positive ion mode; Figure 4J This is the total ion current of drug-containing serum collected 6 hours ago in negative ion mode; Figure 4K This is the total ion current of drug-containing serum collected at 8 hours in positive ion mode; Figure 4L This is the total ion current of drug-containing serum collected at 8 hours in negative ion mode; Figure 4M It is the total ion current of drug-containing serum collected 24 hours after blood sampling in positive ion mode; Figure 4N This is the total ion current graph of drug-containing serum collected from blood samples taken 24 hours ago in negative ion mode.

[0023] Figure 5 It is the metabolic pathway of kaempferol, astragalus glycoside, and quercetin.

[0024] Figure 6 It is the apigenin metabolic pathway.

[0025] Figure 7 This is the response intensity-time curve of 14 kinds of salt dodder components entering the blood.

[0026] Figure 8 It is the best concentration and best time for screening the serum containing salt dodder seeds.

[0027] Fig. 9 These are the results of the effect of Cuscuta australis serum on HUVEC cell proliferation at different time points.

[0028] Fig.10 The effect of drug-containing serum on HUVEC cell angiogenesis at different time points. DETAILED DESCRIPTION

[0029] 1. Preparation of salt dodder decoction

[0030] Take clean dodder seeds, add salt water, mix well, simmer thoroughly, put in a wok, heat over low heat, stir-fry until slightly swollen, take out, and let cool. (Use 2g salt for every 100g clean dodder seeds). Soak salt dodder seeds in distilled water for 30min, boil 10 times water over high heat, then simmer for another 30min over low heat, filter with gauze and keep the supernatant, add 8 times distilled water to the residue and process it once more, filter and discard the residue, combine the two filtrates, and concentrate to a concentration of 1.08g / mL.

[0031] 2. Preparation of serum containing salt dodder seeds

[0032] SPF SD female rats were randomly divided into 7 groups, namely blank serum group, 1h, 2h, 4h, 6h, 8h, 24h group, 5 rats in each group, and began to be gavaged (10.8g / kg) after one week of adaptive feeding, once / 1d, for 7 consecutive days. After the last gavage (1h, 2h, 4h, 6h, 8h, 24h), blood was collected from the abdominal aorta with 10% urethane anesthesia, left to stand for 1-2h, and centrifuged at 3500rpm for 10min to obtain rat serum samples.

[0033] 3. Preparation of mixed standards

[0034] Accurately weigh 1 mg each of the reference substances astragalus glycosides, quercetin, isoquercetin, kaempferol, isorhamnetin, and palmitic acid, add 10 mL of methanol to dissolve and make up to volume to prepare the reference substance stock solution. Take 1 mL of each reference substance solution and add methanol to prepare a 10 μg / mL mixed reference substance solution.

[0035] 4. Serum sample pretreatment

[0036] Take 300μL of serum sample, add 1000μL of extraction solution (methanol: water = 4:1), vortex for 30s, let stand at -40℃ for 1h, then centrifuge at 4℃, 12000rpm for 15min, and take the supernatant through a 0.22μm filter. Take 400μL of serum, add 40μL of hydrochloric acid (2mol / L), vortex for 1min, let stand at 4℃ for 15min, repeat vortexing and let stand four times, add 1.6mL of acetonitrile, vortex for 5min, centrifuge at 12000rpm / min for 5min, take 1800μL of supernatant and blow dry with nitrogen. Add 150μL of 80% methanol (internal standard concentration is 10μg / mL) to re-dissolve, vortex for 5min, and centrifuge at 12000rpm for 5min. Take 120μL of supernatant into the injection bottle and test on the machine.

[0037] 5. UHPLC-Q / TOF-MS analysis

[0038] Sample analysis was performed on an ultra-high performance liquid chromatography (Nexera UHPLC LC-30A) coupled with a quadrupole time-of-flight tandem mass spectrometer (Triple TOF 5600, AB Sciex). The mobile phase of Waters UPLC BEH C18 column (2.1mm×100mm,1.7μm) was (A) 0.1% formic acid in water and (B) 0.1% formic acid in acetonitrile, and the elution gradient was as follows: 0-3.5min, 5%-15% B; 3.5-6.0min, 15%-30% B; 6.0-6.5min, 30% B; 6.5-12min, 30%-70% B; 12-12.5min, 70% B; 12.5-18min, 70%-100% B; 18-25min, 100% B; 25-26min, 100%-5% B; 26-30, 5% B. Flow rate: 0.4mL / min, injection volume 5μL.

[0039] Data acquisition was performed in positive and negative ion electrospray (ESI) modes. The parameters were set as follows: bombardment energy: 40 eV, collision energy difference: 20 V, nebulizer pressure (GS1): 55 Psi, auxiliary pressure: 55 Psi, curtain gas pressure: 35 Psi, temperature: 550 °C, spray voltage: 5500 V (positive ion mode) or -4000 V (negative ion mode).

[0040] 6. Data Analysis

[0041] First, a database of chemical components contained in the traditional Chinese medicine Cuscuta was established through databases such as CNKI and PubMed, including information such as name, chemical molecular formula, molecular weight, and structural formula. The original data of the salt Cuscuta sample solution and the established Cuscuta chemical component library were imported into the XIC Manager tool in Peakview software to complete the screening of target compounds. Peakview threshold settings: XIC intensity>100 counts, signal-to-noise ratio S / N>10, molecular mass error≤5ppm, retention time error≤5ppm, isotope ratio difference≤10ppm, in negative ion mode, [MH]- was selected as the adduct ion; in positive ion mode, [M+H]+ was selected as the adduct ion. The structure of the compound was confirmed by Chemdraw software combined with literature and secondary fragmentation rules. As shown in Figure 1, total ion chromatograms TICs in positive and negative ion modes were obtained, and 37 in vitro compounds were characterized (Table 1), including 19 flavonoids, 6 phenylpropionic acid compounds, 5 fatty acid compounds, 3 lignans, 2 coumarins, 1 phenolic acid compound, and 1 ester compound. Then we performed secondary mass spectrometry fragmentation analysis on the typical components hyperoside and isochlorogenic acid C. Figure 2 and Figure 3 shown.

[0042] Table 1 In vitro chemical composition information of Cuscuta australis

[0043]

[0044] Step 2: Based on the screened in vitro chemical components of Cuscuta chinensis, the prototype blood-entering components were screened. The blank serum and salt Cuscuta chinensis drug-containing serum sample data at different time points within 24 hours were imported into the XIC Manager tool of Peakview software, and the ratio of blank sample response intensity was set to 10%. The relative retention time (RT), mass error and fragmentation behavior were compared to identify the serum prototype components. As shown in Figure 4, we obtained the total ion chromatograms of the blank group and the salt Cuscuta chinensis group serum samples at different time points, and a total of 11 prototype blood-entering components related to salt Cuscuta chinensis were detected (Table 2).

[0045] Table 2 Information on blood components of Cuscuta australis

[0046]

[0047] Step 3: Establish an analytical method to predict and screen metabolites from the prototype components. The biotransformation of drugs in the body includes phase I and phase II metabolic reactions. The blank serum and drug-containing serum sample data were imported into Peakview software, and the metabolites were preliminarily screened according to the parameters of serum prototype component identification, and the metabolite information was further determined in combination with the literature and metabolic pathway cleavage rules. 12 metabolites were identified in rat serum. The prototype components, mainly flavonoids such as kaempferol, apigenin, and isorhamnetin, undergo phase I and phase II metabolic reactions mainly based on hydroxylation, methylation, and glucuronidation to produce a series of metabolites (Table 3). A total of 10 flavonoid-related metabolites (M3, M4, M5, M6, M7, M8, M9, M10, M11, and M12) were preliminarily identified, among which the M5 metabolite is derived from the glucuronidation of kaempferol or the conversion of methylene to ketone by astragaloside. M12 is derived from the methylation of quercetin or the hydroxylation + methylation of kaempferol, such as Figure 5 shown.

[0048] Table 3 Information on metabolites of Cuscuta australis

[0049]

[0050] Apigenin can promote vascular endothelial cells and have anti-inflammatory and anti-infective effects by regulating the expression of endothelial nitric oxide synthase (eNOS) and VEGF. The presence of excessive inflammatory response at the maternal-fetal interface is an important cause of miscarriage. After reviewing and analyzing the literature, we speculate that it mainly undergoes five transformations in the body, and the metabolic pathways are shown in the figure. M3, M4, M8 and M10 are metabolized by apigenin through glucuronidation, hydroxylation + glucuronidation, hydroxylation + sulfidation, and hydroxylation, respectively. Figure 6 Then we confirmed the common components of 14 salt dodder seeds in rat serum at 6 time points, and drew the response intensity-time curve according to the different response intensities of each component in the mass spectrometer at different time points, as shown in Figure 2. Figure 7 As shown, the response intensity and content of each component in rat serum changed at different time points, indicating that there were significant differences in the absorption and metabolism process of each component in the body.

[0051] 7. Screening of serum concentration of Cuscuta australis

[0052] HUVEC cells in the logarithmic growth phase were selected and when the fusion rate in the T-25 culture flask reached 100%, 5×10 3 The cells were inoculated at a certain density in a 96-well plate and divided into a control group and a drug-containing serum group. After the cells adhered to the wall, different concentration gradients of salt dodder-containing serum (2.5%, 5%, 10%, 20%, 40%) were used to intervene in the cells and cultured at different time points (24h, 48h, 72h). Six replicates were set up for each group. CCK8 detection was performed at the corresponding time. 10% CCK8 solution was added to each well. At the same time, a blank group containing only CCK8 solution and culture medium was set up. After continuing to culture in the dark for 2 hours, the absorbance value (OD value) was detected at a wavelength of 450nm using an enzyme-linked immunosorbent assay. Figure 8 As shown, 20% salt dodder serum containing medicated serum cultured for 48 hours had the best effect on promoting the proliferation of HUVEC cells, and there was a significant difference. Therefore, we chose 20% salt dodder serum containing medicated serum cultured for 48 hours for subsequent experimental treatments.

[0053] 8. Effects of serum containing salt dodder seeds on cell proliferation at different time points

[0054] HUVEC cells in the logarithmic growth phase were collected and 5×10 3The cells were seeded at a density of cells / 100μL in a 96-well plate, and 100μL PBS solution was added to the edge wells to prevent edge effect. The cells were intervened with the salt dodder serum at different time points. The cells were divided into a blank serum group and a salt dodder serum group (1h, 2h, 4h, 6h, 8h, 24h). After 48h, the original serum culture medium was discarded, and 10% CCK8 solution was added to each well. After incubation in the dark for 2h, the absorbance (OD value) of each well was detected at a wavelength of 450nm using a microplate reader. Fig. 9 As shown, the serum containing salt dodder seeds at each time point (1h, 2h, 4h, 6h, 8h, 24h) can promote the proliferation of HUVEC cells, among which the serum containing 2h has the most obvious proliferation-promoting effect, and there is a significant difference among each group.

[0055] 9. Angiogenesis Experiment

[0056] Place Matrigel in a 4°C refrigerator to thaw, pre-cool the 96-well plate, pipette tip, and EP tube in advance, take 60 μL of Matrigel per well, add it evenly and cover the 96-well plate, make sure there are no bubbles, let it stand in a 4°C refrigerator for 10 minutes, then place it in an incubator and let it stand for another 30 minutes. Take the cells in the logarithmic growth phase for digestion and resuspend. Take the 96-well plate with the gel solidified from the incubator, and immediately add 100 μL of cell suspension (1×10 4 After the cells adhered to the wall, the drug was administered at the optimal concentration of drug-containing serum. After 12 hours, the formation and number of blood vessels were observed under a microscope and images were collected. The number and length of branches of the formed tubes were statistically analyzed using Image J software. Fig.10 As shown in the figure, in terms of the number of vascular branches, the salt dodder serum containing 2h, 4h, 6h, and 24h can promote the angiogenesis of HUVEC cells, but the angiogenic ability of the 1h and 8h medicated serum is not significantly different from that of the control group. Among them, the effect of 2h on promoting the increase of the number of vascular branches is the best. As the time of the medicated serum in the body increases, its tube-forming ability gradually decreases, but the 24h medicated serum has a callback effect on the formation of vascular branches. In terms of the length of vascular formation, the salt dodder serum containing 2h, 4h, and 24h can promote the extension of blood vessels. There is no significant difference in the extension of blood vessels with the 1h, 6h, and 8h medicated serum, but the 24h medicated serum has a callback effect on the extension of blood vessels.

[0057] 10. Spectrum-effect correlation analysis Grey correlation analysis was performed based on the efficacy indexes of promoting angiogenesis and the blood components of salt dodder, and the degree of correlation between the factors was judged by the similarity between the curves. When the trend of the efficacy index and the response intensity of the serum component is basically consistent, the gray value is large and the correlation between the two is high, otherwise the correlation is small. The chemical components associated with the time change of drug efficacy were screened to explore the quality markers of salt dodder promoting angiogenesis. The ranking results of the grey correlation analysis of the common in vivo components of 14 salt dodders at different time points are shown in Table 4. The top 10 are mainly flavonoids and their metabolites, indicating that the metabolites of the compounds also play an important role in the treatment process, among which kaempferol-3-O-β-D-glucuronide ranks first, so kaempferol-3-O-β-D-glucuronide should be the main material basis for the efficacy of salt dodder.

[0058] Table 4 Grey correlation and ranking results of chemical components in rat serum

[0059]

Claims

1. A method for detecting angiogenesis-promoting quality markers of Cuscuta australis, characterized in that: The following steps are included: S1: preparing salt dodder seed extract solution; S2: Rats were given drugs by intragastric administration, and blood was collected after the last intragastric administration. The blood serum samples containing drugs were obtained by centrifugation. S3: Weigh the reference substances astragalus glycosides, quercetin, isoquercetin, kaempferol, isorhamnetin, and palmitic acid, add methanol to prepare the reference substance solution, take each reference substance solution, and add methanol to prepare a mixed reference substance solution; S4: adding the extracting solution to the serum sample obtained in S2, vortexing, nitrogen blowing, and re-dissolving, to obtain a serum sample that can be used in the instrument; S5: Analyze the samples in S1, S2 and S4 using ultra-high performance liquid chromatography-quadrupole / time-of-flight-mass spectrometry to characterize the in-situ and in-situ chemical components of Cuscuta salinarum and draw the response intensity-time curve; S6: The angiogenesis-promoting effect of the salt dodder seed-containing serum at different time points in S2 was evaluated using multiple efficacy evaluation indicators, and the efficacy-time curve was drawn; S7: Fit the response intensity-time curves of each serum migration component in S5 with the efficacy-time curve in S6 to construct a "spectrum-effect" relationship model, and detect the quality markers of promoting angiogenesis through correlation analysis and grey correlation analysis method.

2. The method for detecting angiogenesis-promoting quality markers of Cuscuta australis according to claim 1, characterized in that: The method for preparing the salt dodder seed extract in step S1 is as follows: take clean dodder seeds, add salt water and mix well, simmer thoroughly, put in a wok, heat over low heat, fry until slightly swollen, take out, and cool; soak the salt dodder seeds in distilled water, boil over high heat and then simmer over low heat, filter with gauze to retain the supernatant, add distilled water to the filter residue and treat it in the same way, discard the residue after filtering, combine the filtrate, and concentrate the filtrate.

3. The method for detecting the quality marker of angiogenesis promoted by Cuscuta australis according to claim 1, characterized in that: In step S3, the concentration of the mixed reference solution is prepared to be 10 μg / mL.

4. The method for detecting angiogenesis-promoting quality markers of Cuscuta australis according to claim 1, characterized in that: The chromatographic conditions of the high performance liquid chromatography in step S5 are: Waters UPLC BEH C18 chromatographic column mobile phase A: 0.1% formic acid aqueous solution and phase B: 0.1% formic acid acetonitrile; mass spectrometry conditions are: bombardment energy: 40eV, collision energy difference: 20V, nebulization pressure: 55Psi, auxiliary pressure: 55Psi, curtain pressure: 35Psi, temperature: 550°C, spray voltage: 5500V positive ion mode or -4000V negative ion mode.

5. The method for detecting angiogenesis-promoting quality markers of Cuscuta australis according to claim 1, characterized in that: The efficacy evaluation indicators of salt dodder in promoting angiogenesis described in step S6 are the effect of salt dodder serum on the proliferation activity of human umbilical vein endothelial cells (HUVEC), the effect of salt dodder serum on the number of vascular branches of HUVEC cells, and the effect of salt dodder serum on the length of blood vessel formation of HUVEC cells.

6. The method for detecting angiogenesis-promoting quality markers of Cuscuta australis according to claim 1, characterized in that: Step S7 sets the drug efficacy-time curve as the parent sequence variable, and the response intensity-time curve of each component as the characteristic sequence variable, calculates the correlation between the two, and screens the chemical components associated with the time change of drug efficacy.

7. An application of a salt dodder angiogenesis promoting quality marker obtained by the detection method according to any one of claims 1 to 6 in a salt dodder quality detection product, characterized in that: The angiogenesis-promoting quality marker includes: kaempferol-3-O-β-D-glucuronide.

8. The use according to claim 7, characterized in that The angiogenesis-promoting quality markers also include the following compounds: caffeic acid, kaempferol, apigenin, isorhamnetin, and quercetin.

9. The use according to claim 7 or 8, characterized in that The angiogenesis-promoting quality markers also include compounds with the following chemical structures:

10. The use according to claim 7 or 8, characterized in that: The angiogenesis-promoting quality markers also include compounds with the following chemical structures:

Citation Information

Cited By

  • Screening method of potential quality difference marker of Mongolian medicine Darbibu-5

    CN119355178A

  • Method for analyzing angiogenesis promoting mechanism of qi-regulating and blood-activating dropping pills based on network pharmacology

    CN121075700A